secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2026-05-12T20:46:03+00:00
Accession:  0001437749-26-016455
Event type: other_material
Sentiment:  negative
Materiality: 0.95
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key receives Nasdaq delisting notice; stock to move to OTC Markets on May 13
--------------------------------------------------------------------------------

- Nasdaq suspends BKYI trading after close May 12 for failing to maintain $1 bid price for 10 consecutive days by May 4 and late Form 10-K.
- Company will request a hearing before a Nasdaq Hearings Panel to appeal delisting; no guarantee of reinstatement.
- Stock to be quoted on OTC Markets under symbol BKYI starting May 13; reverse stock split was effective April 30 but timing fell short.
- CEO states 1H'26 revenue expected to rise 50% to $5M vs $3.3M in 1H'25; targets profitability vs $1.9M net loss in 1H'25.
- Cash position expected to remain in line with year-end 2025 level; company retains listing consultants to expedite Nasdaq return.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774926016455/0001437749-26-016455-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774926016455/bkyi20260512_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-016455

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer